A Janus kinase inhibitor was approved for the treatment of active polyarticular course juvenile idiopathic arthritis among patients aged 2 years or older.
Recent research called the effects of dairy products on fracture risk into question. Following this controversial news, a group of researchers conducted a systematic review of more than 90 studies to...
A recent study sought to examine whether replacing NSAIDs such as meloxicam with placebo and cognitive behavioral therapy was as effective as continuing NSAID treatment in patients with knee...
Because the association between influenza and the risk of fractures and fall injuries among older adults is unclear, a team of researchers assessed this relationship. Their results were presented in...
Researchers sought to determine the ways in which rheumatoid arthritis impacts the risk of myocardial infarction, major adverse cardiovascular events, and all-cause mortality among patients with and without...
In a new literature review, researchers aimed to better understand the connection between high daily intake of vitamin C and the development, prevention, and treatment of osteoporosis.
There has been scant study of outcomes related to surgery among patients with vertebral osteomyelitis, though the condition often causes chronic pain and functional limitations. Researchers investigated...
Authors of a new study sought to identify early predictors of disease activity at 18 months using clinical and biomarker profiling among patients with juvenile idiopathic arthritis.
The US Food and Drug Administration has approved tofacitinib for the treatment of active polyarticular course juvenile idiopathic arthritis among pediatric patients aged 2 years or older.
